Senseonics Holdings

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Senseonics achieves FDA milestone with Eversense 365, focuses on growth

Senseonics had a pivotal quarter with FDA approval of Eversense 365, driving positive feedback and strong adoption.
Financially, the company reported Q3 net revenue of $4.3 million with a gross loss of $4.1 million, focusing on cost reduction.
Efforts to reduce operating expenses and extend cash runway aim to address financial challenges and enhance stability.
With opportunities to accelerate sales, improve diabetes management, and expand market reach, Senseonics is poised for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan (the “Plan”) in accordance with NYSE American Company Guide Section 711(a). On April 1, 2022, Senseonics Compensation Committee granted 17 new non-execu

Senseonics Announces Equity Grants to Employees Under Inducement Plan

Vinco Ventures

Borr Drilling Ltd

Meten Holding Group Ltd.

These penny stocks are climbing today, here's why The post Best Penny Stocks to Buy Right Now? 4 to Watch As Stocks Turn Bullish appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks to Buy Right Now? 4 to Watch As Stocks Turn Bullish

Senseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue Estimates

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q4 2021 Results - Earnings Call Transcript

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights & Accomplishments: Received approval from the Food and Drug Administration (FDA) for the Eversense® E3 CGM System, offering patients: Fu

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

Farmmi

Exela Technologies

How to trade penny stocks in 2022, three things to know The post What is Affecting Penny Stocks in 2022? 3 Must-Knows For Trading appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What is Affecting Penny Stocks in 2022? 3 Must-Knows For Trading

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and full year 2021 financial results after market close on Tuesday, March 1, 2022. Management will hold a conference call to review the Company's fourth quarter and full year 2021 pe

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4:30 p.m. Eastern Time

PARSIPPANY, N.J., Feb. 14, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, announces that its partner Senseonics Holdings, Inc. (NYSE American: SENS) has received approval from the U.S. Food and Drug Administration (FDA) for the next-generation Eversense® E3 Continuous Glucose Monitoring (CGM) System.

ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS

Gevo

New Gold

Check these three penny stocks out right now The post 3 Hot Penny Stocks to Watch as February Continues appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks to Watch as February Continues

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the approval of the next-generation Eversense® E3 CGM System by the Food and Drug Administration (FDA). The Eversense E3, including proprietary sacrificial boronic acid (SBA) technology to extend longevity to 6 months, is planned

Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook

Yamana Gold

Didi Global

Here are three penny stocks to watch this month The post 3 Hot Penny Stocks to Add to Your February 2022 Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks to Add to Your February 2022 Watchlist

Express

Palisade Bio

Here are 5 penny stocks to watch this week The post Best Penny Stocks To Buy This Week? 5 Names You Should Know Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy This Week? 5 Names You Should Know Now

Skillz

Southwestern Energy

Here are four penny stocks to watch right now The post Top 4 Penny Stocks to Watch Today as the Market Turns Bullish appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top 4 Penny Stocks to Watch Today as the Market Turns Bullish

Iterum Therapeutics Plc

Phunware Inc

Why investors are watching these penny stocks right now The post Hot Penny Stocks to Watch in Early February 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks to Watch in Early February 2022

Epizyme

Inspira Technologies Oxy BHN Ltd

Here are three penny stocks to check out today The post 3 Hot Penny Stocks to Watch Under $4 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks to Watch Under $4 Right Now

Context Therapeutics LLC

Flotek Industries

Are these on your list of the best penny stocks to buy right now? Here's what analysts think The post 4 Penny Stocks To Buy Now According To Analysts, Targets Over 300% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks To Buy Now According To Analysts, Targets Over 300%

Hudson Technologies

Martin Midstream Partners

Pangaea Logistics Solutions

Safe Bulkers

TransGlobe Energy

Target Hospitality Corp

The economy is heating up and that's great news for penny stocks because they thrive when the market kicks into high gear. The post 7 A-Rated Penny Stocks That Are Worth a Gamble Now appeared first on InvestorPlace.

7 A-Rated Penny Stocks That Are Worth a Gamble Now

KLX Energy Services Holdings Inc

SeaChange International

Short squeeze penny stocks to watch this week The post Hot Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Short Squeeze Penny Stocks To Buy For Under $5 Right Now

Destination XL Group

Entravision Communications

Information Services Group

Nokia

Prospect Capital

Each of these stocks to buy for January are under $10. They encompass a variety of industries and each score high in Portfolio Grader.

7 Stocks to Buy Under $10 in January

Stran & Co

Do these penny stocks have short squeeze potential? The post 3 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Short Squeeze Penny Stocks To Buy For Under $5 Right Now

Castlight Health

Lixte Biotech

Should you add these penny stocks to your watchlist this month? The post Best Penny Stocks to Buy Today?

Best Penny Stocks to Buy Today? 3 For Your Watchlist

The stock price of Senseonics Holdings Inc (NYSEAMERICAN: SENS) increased by over 14% pre-market today. This is why it happened.

Senseonics Holdings Stock (SENS): Why The Price Surged Today

SENS stock is up nearly 20% on Wednesday after Senseonics said an FDA decision for its glucose monitoring system is pending. The post SENS Stock Alert: Why Is Senseonics Heating Up Today?

SENS Stock Alert: Why Is Senseonics Heating Up Today?

Issuing an operational update, Senseonics Holdings Inc (NYSE:SENS) said FDA review for the PMA supplement for the next generation Eversense 180-day CGM system is nearing completion. All queries raised have been answered, and an approval decision is expected in the coming weeks.

Senseonics Expects FDA Nod For Next-Gen Eversense Glucose Monitoring System In Coming Weeks

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced operational and financial business updates. Operational and Financial Updates Substantive review with the FDA for the PMA supplement for the next generation Eversense 180-day CGM system is nearing completion, all queries raised ha

Senseonics Announces Business Updates

News for Senseonics Holdings Stock (SENS)